PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release

Bicyclic nitroimidazoles, including PA-824, are exciting candidates for the treatment of tuberculosis. These prodrugs require intracellular activation for their biological function. We found that Rv3547 is a deazaflavin-dependent nitroreductase (Ddn) that converts PA-824 into three primary metabolit...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Singh, Ramandeep, Manjunatha, Ujjini, Boshoff, Helena I. M., Ha, Young Hwan, Niyomrattanakit, Pornwaratt, Ledwidge, Richard, Dowd, Cynthia S., Lee, Ill Young, Kim, Pilho, Zhang, Liang, Kang, Sunhee, Keller, Thomas H., Jiricek, Jan, Barry, Clifton E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2008
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2723733/
https://ncbi.nlm.nih.gov/pubmed/19039139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.1164571
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items